AOLS — Aeolus Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.02m
- -$0.39m
- $2.08m
Annual cashflow statement for Aeolus Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2012 September 30th | 2013 September 30th | 2014 September 30th | 2015 September 30th | 2016 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.7 | -3.21 | -0.08 | -2.63 | -3.56 |
| Depreciation | |||||
| Non-Cash Items | -3.5 | 1.37 | 0.635 | 0.178 | 0.426 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.917 | -1.14 | -0.232 | 0.007 | 0.023 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.879 | -2.97 | 0.323 | -2.44 | -3.11 |
| Capital Expenditures | 0 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | 0 | — | — | — |
| Financing Cash Flow Items | -0.018 | -0.058 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.642 | 3.56 | 0.325 | 1.02 | 6.17 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.237 | 0.588 | 0.648 | -1.42 | 3.06 |